^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

huCART19

i
Other names: huCART19, huCTL019, huCART-19 T cell therapy, CTL119, CTL 119, CTL-119
Associations
Company:
Novartis, University of Pennsylvania
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations